A developmental drug designed to help dogs with Brachycephalic Obstructive Airway Syndrome (BOAS) breathe easier showed ...

A stick-on gel for plants could one day offer a simple, safe and targeted way to treat diseases and pests. Engineers at the ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

Johnson & Johnson is using artificial intelligence to slash by half the time it ‌takes to generate new leads for developing ...

Inc., a Boston-based clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise ...

Humana announced on Monday it will launch a pharmacy ​partnership with Mark Cuban's Cost Plus ‌Drugs, with the health ...

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the ...

Epic Systems was named to Time’s list of the most influential health and life sciences companies of 2026. The ranking, released April 27, is part of Time’s expanded TIME100 Companies franchise, which ...

With Phase 3 data in hand, Intellia Therapeutics is seeking approval for its in vivo CRISPR gene editing therapy for ...

Technology tycoons Elon Musk and Sam Altman are poised to face off in a high-stakes trial revolving around artificial ...

Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, ...

MIT researchers discovered a paradoxical phenomenon in optical physics that could enable a new bioimaging method that's ...